Clinical trials show progress in migraine frequency, skin cancer prevention
-
2:54
Family members hold vigil for Milwaukee 16-year-old shot and...
-
1:04
Ukrainian war veterans share stories of service, resilience at...
-
0:52
Fiesta Selena postponed by rain, but celebration continues indoors...
-
0:52
Wine and Harvest Festival draws crowds to downtown Cedarburg...
-
1:30
Hobb’s Woods
-
3:13
Bookstore in Whitefish Bay bringing the community together one...
-
4:00
Mobile lemonade business stirs up something sweet
-
3:50
‘A caricature of words’: Milwaukee man uses old typewriter...
-
3:23
Rain wrapping up soon, dry & cool to start fall
-
3:30
Gas prices in Wisconsin reach near $5 a gallon at some locations...
-
0:21
16-year-old dies after shooting on South Layton Boulevard in...
-
1:04
Statue honoring Milwaukee housing pioneer Beechie O. Brooks unveiled...
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.